|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.86 USD | +2.68% |
|
+7.74% | +18.32% |
| 06-30 | FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications | RE |
| 06-29 | Incyte Corporation(NasdaqGS:INCY) dropped from Russell Midcap Growth Benchmark | CI |
| Market Cap | 22.74B 19.89B 18.27B 17.03B 32.24B 2,169B 32.86B 220B 85.2B 1,057B 85.34B 83.51B 3,664B | P/E 2026 * |
16.5x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 17.72B 15.5B 14.24B 13.27B 25.13B 1,690B 25.61B 171B 66.4B 823B 66.5B 65.08B 2,855B | EV / Sales 2026 * |
3.14x | EV / Sales 2027 * | 2.55x |
| Free-Float |
98.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Incyte Corporation
| 1 day | +2.68% | ||
| 1 week | +7.74% | ||
| Current month | +3.09% | ||
| 1 month | +22.25% | ||
| 3 months | +23.92% | ||
| 6 months | +18.32% | ||
| Current year | +18.32% |
| 1 week | 109.48 |  | 118.69 |
| 1 month | 92.66 | | 118.69 |
| Current year | 89.25 | | 118.69 |
| 1 year | 66.85 | | 118.69 |
| 3 years | 50.27 | | 118.69 |
| 5 years | 50.27 | | 118.69 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 25/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 03/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 04/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 25/06/2025 |
| Director/Board Member | 72 | 19/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 19/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Free | Director | 7,753 | 0.0039% | ||
| 06-07 | FBS Associates LLC
| Other | Company | 0 | 0% | |
| 06-07 | Baker Bros. Advisors LP
| Free | Company | 15,506 | 0.0078% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.68% | +7.74% | +70.03% | +87.73% | 22.74B | |
| +4.73% | +4.95% | +22.31% | -8.94% | 63.56B | |
| +2.60% | +3.76% | +58.59% | +225.86% | 55.92B | |
| +0.72% | +40.60% | +40.60% | +40.60% | 41.68B | |
| -0.52% | +2.40% | -50.58% | -57.55% | 39.12B | |
| +3.04% | +8.28% | +66.16% | -24.13% | 30.97B | |
| +10.01% | +32.01% | +178.01% | -34.35% | 28.77B | |
| +7.22% | +9.49% | +8.86% | +188.34% | 17.64B | |
| +2.43% | +1.78% | +68.16% | +127.95% | 16.66B | |
| +3.58% | +11.29% | +80.43% | +348.78% | 14.6B | |
| Average | +2.71% | +5.35% | +54.26% | +89.43% | 33.16B | |
| Weighted average by Cap. | +2.56% | +4.48% | +47.15% | +67.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.65B 4.94B 4.54B 4.23B 8.01B 538B 8.16B 54.63B 21.16B 262B 21.19B 20.74B 910B | 6.22B 5.44B 5B 4.66B 8.82B 593B 8.99B 60.16B 23.3B 289B 23.34B 22.84B 1,002B |
| Net income | 1.44B 1.26B 1.15B 1.08B 2.04B 137B 2.08B 13.91B 5.39B 66.78B 5.39B 5.28B 232B | 1.67B 1.46B 1.35B 1.25B 2.37B 160B 2.42B 16.2B 6.27B 77.78B 6.28B 6.15B 270B |
| Net Debt | -5.02B -4.39B -4.03B -3.76B -7.12B -479B -7.25B -48.56B -18.81B -233B -18.84B -18.43B -809B | -6.87B -6.01B -5.52B -5.15B -9.75B -656B -9.93B -66.51B -25.76B -319B -25.8B -25.25B -1,108B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$116.85 | +2.67% | 2,615,607 |
| 01/07/26 | US$113.81 | +0.40% | 1,711,033 |
| 30/06/26 | US$113.36 | -1.13% | 1,830,643 |
| 29/06/26 | US$114.66 | +0.80% | 1,532,380 |
| 26/06/26 | US$113.75 | +5.78% | 3,795,266 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
